03 Nov 2016 --- DSM continues to expect to deliver full-year 2016 results ahead of the medium-term targets set out in its Strategy 2018, the companies Q3 2016 sales increased by 4% compared to Q3 2015, with a good organic sales growth of 5%. Volumes were up by 3% and price/mix up 2%, driven by higher vitamin prices. Exchange rates had a 1% negative impact on sales, mainly due to a slightly weaker US dollar.
